sur Medacta Group SA (isin : CH0468525222)
Medacta Group SA Reports 14.3% Revenue Growth at Constant Currency in 1H 2024
Medacta Group SA announced a 14.3% growth in revenues at constant currency for the first half of 2024, reaching €288.6 million, compared to the same period in 2023. The EMEA region led with a 16.6% increase, followed by APAC with 12.6% and North America with 11.1% growth.
The company saw significant performance in its Knee and Shoulder business lines, with revenues increasing by 18.6% and 39.6% respectively. CEO Francesco Siccardi highlighted the company's commitment to sustainable innovation and personalized medicine during its 25th Anniversary World Tour.
Medacta continues to expand its supply chain and industrial facilities while focusing on medical education through global scientific events. The official half-year results will be released on September 25, 2024.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Medacta Group SA